Approval · Notice of Compliance 13280 · 2012
ANDRODERM: Notice of Compliance 13280
Issued May 17, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13280
- Date
- May 17, 2012
- Company
- Watson Laboratories IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Androgens
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDRODERM | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE 12.2 MG per PATCH
- TESTOSTERONE 24.3 MG per PATCH